September 11, 2025 09:00 ET | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows more than 50% reduction in photoreceptor loss caused…
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…
With 95% of enterprises facing incidents, Infosys research reveals wide gap between AI adoption and responsible AI readiness, exposing most…
New York City, NY, Aug. 02, 2025 (GLOBE NEWSWIRE) -- TrimIQ UK, a pioneering health and wellness brand, proudly announces…
- India faces an annual loss of approximately $1.65 billion, with 25% of the domestic market illicit and an estimated…
Albany, New York, July 26, 2025 (GLOBE NEWSWIRE) -- An internet-viral pink salt recipe has swept the TikTok platform purporting…
Monday 21 July, 2025 PRESS RELEASE FOR IMMEDIATE RELEASE Justice4Heroes Campaign Demands Equality in Military Hearing Loss Compensation UK –…
Albany, New York, July 15, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of fitness and bodybuilding, achieving optimal muscle…
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of…
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25%…